Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16
Author:
Affiliation:
1. JMI Laboratories, North Liberty, IA, USA
2. University of Iowa, Iowa City, IA, USA
Funder
Allergan
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Link
http://academic.oup.com/jac/article-pdf/73/10/2748/25770283/dky235.pdf
Reference38 articles.
1. The rise of the Enterococcus: beyond vancomycin resistance;Arias;Nat Rev Microbiol,2012
2. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic;David;Clin Microbiol Rev,2010
3. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management;Tong;Clin Microbiol Rev,2015
4. Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies?;van Harten;Trends Microbiol,2017
5. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014;Weiner;Infect Control Hosp Epidemiol,2016
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview;Global and Regional Health Technology Assessment;2024-07-29
2. Recent development and fighting strategies for lincosamide antibiotic resistance;Clinical Microbiology Reviews;2024-06-13
3. Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance;Clinical Microbiology Reviews;2024-06-13
4. Simulated Target Attainment of Multidose Regimens of Dalbavancin for Prolonged Durations of Therapy;Open Forum Infectious Diseases;2024-06
5. Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience;Antibiotics;2024-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3